Higashimurayama, Japan

Hiroshi Ishihama


Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1984-1988

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Hiroshi Ishihama: Innovator in Cardiovascular Pharmaceutical Development

Introduction

Hiroshi Ishihama is a prominent inventor based in Higashimurayama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for cardiovascular diseases. With a total of 8 patents to his name, Ishihama's work has had a notable impact on medical science.

Latest Patents

Ishihama's latest patents include innovative compounds such as anti-arteriosclerotic pyridyl or imidazolyl derivatives. His work features racemates of a novel compound, K-351A, which is composed of an optical isomer (2'S),(3S)K-351 and (2'R),(3R)K-351. Additionally, he has developed another racemate, K-351B, which includes (2'R),(3S)K-351 and (2'S),(3R)K-351. These compounds are accompanied by a process for converting the two racemates to each other and a pharmaceutical composition that utilizes these racemates for treating cardiovascular diseases.

Career Highlights

Ishihama is currently associated with Kowa Company Limited, where he continues to advance his research and development efforts. His work has been instrumental in creating effective pharmaceutical solutions that address critical health issues.

Collaborations

Ishihama has collaborated with notable colleagues such as Yasumi Uchida and Setsuro Fujii, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Hiroshi Ishihama's contributions to the pharmaceutical industry, particularly in cardiovascular treatments, highlight his role as a leading inventor. His innovative patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…